Therapy News and Research

RSS

Tailored acupuncture reduces pain intensity, improves quality of life in people with fibromyalgia

Nine weekly sessions of individually tailored acupuncture lessen perceived pain intensity, and improve functional capacity and quality of life, in people with the chronic pain condition, fibromyalgia, finds research published online in Acupuncture in Medicine.

16 Feb 2016

First two patients treated in multi-center clinical trial for perivascular renal denervation

Ablative Solutions, Inc. (ASI), a privately held company headquartered in Kalamazoo, MI, with offices in Palo Alto, CA, announced today that Professors Wojtek Wojakowski and Mariusz Hochul have treated the first two patients in the European Peregrine Post-Market Study.

16 Feb 2016

UAB research reveals heterogonous population of leukemia stem cells

University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment.

16 Feb 2016

Regrowing dopaminergic neurons may lead to new therapy for Parkinson's disease

While scientists are unsure of the molecular causes of Parkinson's Disease, they do know the disorder's tremors and other motor dysfunctions are linked to a loss of dopaminergic neurons located in the substantia nigra, a structure in the midbrain.

16 Feb 2016

NAU researcher calls for greater public awareness of cytomegalovirus

As the Zika virus continues to spread across the globe, and gain worldwide attention for its' potential birth defects, an NAU researcher is calling for greater public awareness of cytomegalovirus—the most common viral cause of birth defects in the United States.

16 Feb 2016

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

Amgen today announced that Kyprolis in combination with lenalidomide and dexamethasone is now available in the UK for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

16 Feb 2016

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

Today, the United Kingdom’s National Institute for Health and Care Excellence has issued positive guidance for the use of Medtronic insulin pump systems integrated with glucose sensors, for managing Type 1 diabetes and the avoidance of potentially life-threatening hypoglycemic episodes.

16 Feb 2016

Research findings identify potential genetics-guided precision medicine for leukemia patients

An international research team has determined how inherited gene variations lead to severe drug toxicity that may threaten chances for a cure in children with leukemia. St. Jude Children's Research Hospital scientists led the study, results of which set the stage to expand the use of a patient's genetic make-up to tailor chemotherapy.

16 Feb 2016

Sonablate HIFU now available in southern California for treatment of prostate cancer patients

HIFU Prostate Services, LLC, a leading provider of minimally-invasive prostate cancer treatment using high intensity focused ultrasound, announces that Sonablate HIFU is now available in southern California through a partnership established with Western States HIFU and Pacific Coast Urology and one of the most experienced HIFU physicians in the world, Robert Pugach, MD.

16 Feb 2016

St. Jude-led scientists explore better ways to use blood-forming stem cells for therapeutic interventions

A team of researchers led by scientists at St. Jude Children's Research Hospital is looking at ways to improve how blood-forming stem cells can be used for therapeutic interventions. The work has uncovered a group of genes that regulate how hematopoietic stem cells start to grow and thrive in mice. The function of many of these genes was previously unknown. Reconstitution of a robust blood-forming system is essential for recovery from many catastrophic diseases as well as from chemotherapy treatments.

16 Feb 2016

Survey: Some patients with multiple sclerosis not engaging with specialist services

A new survey has highlighted that the lack of engagement with specialist services of some patients with multiple sclerosis (MS) is a concern for MS-specialists.

15 Feb 2016

TUM researchers make progress in bringing immunotherapy to fight against cancer, infectious diseases

The quest to bring immunotherapy into widespread clinical use against cancer and infectious diseases has made great strides in recent years.

15 Feb 2016

Most stage III melanoma patients do not benefit from interferon treatment

Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment with interferon.

15 Feb 2016

Mayo Clinic researchers uncover clues to apraxia of speech

It may start with a simple word you can't pronounce. Your tongue and lips stumble, and gibberish comes out. Misspeaking might draw a chuckle from family and friends. But, then, it keeps happening. Progressively, more and more speech is lost. Some patients eventually become mute from primary progressive apraxia of speech, a disorder related to degenerative neurologic disease.

15 Feb 2016

Immersive virtual reality therapy could help reduce depressive symptoms

An immersive virtual reality therapy could help people with depression to be less critical and more compassionate towards themselves, reducing depressive symptoms, finds a new study from UCL (University College London) and ICREA-University of Barcelona.

15 Feb 2016

Nine researchers win EPSRC Healthcare Technologies Challenge Awards

Nine researchers, working on innovative projects that promise to improve healthcare diagnosis and treatment, across a wide spread of issues, were today announced as the first recipients of the Engineering and Physical Sciences Research Council's (EPSRC) Healthcare Technologies Challenge Awards.

15 Feb 2016

Therapy News and Research

Tailored acupuncture reduces pain intensity, improves quality of life in people with fibromyalgia

First two patients treated in multi-center clinical trial for perivascular renal denervation

UAB research reveals heterogonous population of leukemia stem cells

Regrowing dopaminergic neurons may lead to new therapy for Parkinson's disease

NAU researcher calls for greater public awareness of cytomegalovirus

Amgen announces availability of Kyprolis (carfilzomib) in the UK for treatment of relapsed multiple myeloma

NICE issues positive guidance for use of Medtronic insulin therapy systems for managing Type 1 diabetes

Research findings identify potential genetics-guided precision medicine for leukemia patients

Sonablate HIFU now available in southern California for treatment of prostate cancer patients

St. Jude-led scientists explore better ways to use blood-forming stem cells for therapeutic interventions

Survey: Some patients with multiple sclerosis not engaging with specialist services

TUM researchers make progress in bringing immunotherapy to fight against cancer, infectious diseases

Most stage III melanoma patients do not benefit from interferon treatment

Mayo Clinic researchers uncover clues to apraxia of speech

Immersive virtual reality therapy could help reduce depressive symptoms

Nine researchers win EPSRC Healthcare Technologies Challenge Awards

New approach could be used to treat Duchenne muscular dystrophy

Left ventricular tissue phase mapping predicts PAH outcomes

Worsening migraine no reason to halt dihydroergotamine infusion

Trial adds piece to stroke rehabilitation puzzle

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News